Selected research
Industry Growth & Trends
Global Gadopentetate Dimeglumine Industry Growth and Trends Forecast to 2032
Market perspective
The global Gadopentetate Dimeglumine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gadopentetate Dimeglumine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gadopentetate Dimeglumine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gadopentetate Dimeglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gadopentetate Dimeglumine include Consun Pharma, BeiLu Pharma and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gadopentetate Dimeglumine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gadopentetate Dimeglumine market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gadopentetate Dimeglumine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gadopentetate Dimeglumine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Gadopentetate Dimeglumine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gadopentetate Dimeglumine Market by Company
Consun Pharma
BeiLu Pharma
Bayer
Gadopentetate Dimeglumine Segment by Type
15ml: 7.04g
12ml: 5.63g
10ml: 4.69g
Others
Gadopentetate Dimeglumine Segment by Application
Hospitals
Clinics
Gadopentetate Dimeglumine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadopentetate Dimeglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadopentetate Dimeglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadopentetate Dimeglumine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gadopentetate Dimeglumine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Gadopentetate Dimeglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 15ml: 7.04g
- 12ml: 5.63g
- 10ml: 4.69g
- Others
Applications
- Hospitals
- Clinics
Companies covered
- Consun Pharma
- BeiLu Pharma
- Bayer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gadopentetate Dimeglumine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Gadopentetate Dimeglumine Sales Estimates and Forecasts (2021-2032)
- 1.3 Gadopentetate Dimeglumine Market by Type
- 1.3.1 15ml: 7.04g
- 1.3.2 12ml: 5.63g
- 1.3.3 10ml: 4.69g
- 1.3.4 Others
- 1.4 Global Gadopentetate Dimeglumine Market Size by Type
- 1.4.1 Global Gadopentetate Dimeglumine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Gadopentetate Dimeglumine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Gadopentetate Dimeglumine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Gadopentetate Dimeglumine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Gadopentetate Dimeglumine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Gadopentetate Dimeglumine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Gadopentetate Dimeglumine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Gadopentetate Dimeglumine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Gadopentetate Dimeglumine Industry Trends
- 2.2 Gadopentetate Dimeglumine Industry Drivers
- 2.3 Gadopentetate Dimeglumine Industry Opportunities and Challenges
- 2.4 Gadopentetate Dimeglumine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Gadopentetate Dimeglumine Revenue (2021-2026)
- 3.2 Global Top Players by Gadopentetate Dimeglumine Sales (2021-2026)
- 3.3 Global Top Players by Gadopentetate Dimeglumine Price (2021-2026)
- 3.4 Global Gadopentetate Dimeglumine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gadopentetate Dimeglumine Major Company Production Sites & Headquarters
- 3.6 Global Gadopentetate Dimeglumine Company, Product Type & Application
- 3.7 Global Gadopentetate Dimeglumine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gadopentetate Dimeglumine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gadopentetate Dimeglumine Players Market Share by Revenue in 2025
- 3.8.3 2025 Gadopentetate Dimeglumine Tier 1, Tier 2, and Tier 3
4 Gadopentetate Dimeglumine Regional Status and Outlook
- 4.1 Global Gadopentetate Dimeglumine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Gadopentetate Dimeglumine Historic Market Size by Region
- 4.2.1 Global Gadopentetate Dimeglumine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Gadopentetate Dimeglumine Sales in Value by Region (2021-2026)
- 4.2.3 Global Gadopentetate Dimeglumine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Gadopentetate Dimeglumine Forecasted Market Size by Region
- 4.3.1 Global Gadopentetate Dimeglumine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Gadopentetate Dimeglumine Sales in Value by Region (2027-2032)
- 4.3.3 Global Gadopentetate Dimeglumine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gadopentetate Dimeglumine by Application
- 5.1 Gadopentetate Dimeglumine Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Gadopentetate Dimeglumine Market Size by Application
- 5.2.1 Global Gadopentetate Dimeglumine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Gadopentetate Dimeglumine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Gadopentetate Dimeglumine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Gadopentetate Dimeglumine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Gadopentetate Dimeglumine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Gadopentetate Dimeglumine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Gadopentetate Dimeglumine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Gadopentetate Dimeglumine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Consun Pharma
- 6.1.1 Consun Pharma Company Information
- 6.1.2 Consun Pharma Business Overview
- 6.1.3 Consun Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Consun Pharma Gadopentetate Dimeglumine Product Portfolio
- 6.1.5 Consun Pharma Recent Developments
- 6.2 BeiLu Pharma
- 6.2.1 BeiLu Pharma Company Information
- 6.2.2 BeiLu Pharma Business Overview
- 6.2.3 BeiLu Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BeiLu Pharma Gadopentetate Dimeglumine Product Portfolio
- 6.2.5 BeiLu Pharma Recent Developments
- 6.3 Bayer
- 6.3.1 Bayer Company Information
- 6.3.2 Bayer Business Overview
- 6.3.3 Bayer Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bayer Gadopentetate Dimeglumine Product Portfolio
- 6.3.5 Bayer Recent Developments
7 North America by Country
- 7.1 North America Gadopentetate Dimeglumine Sales by Country
- 7.1.1 North America Gadopentetate Dimeglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Gadopentetate Dimeglumine Sales by Country (2021-2026)
- 7.1.3 North America Gadopentetate Dimeglumine Sales Forecast by Country (2027-2032)
- 7.2 North America Gadopentetate Dimeglumine Market Size by Country
- 7.2.1 North America Gadopentetate Dimeglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Gadopentetate Dimeglumine Market Size by Country (2021-2026)
- 7.2.3 North America Gadopentetate Dimeglumine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Gadopentetate Dimeglumine Sales by Country
- 8.1.1 Europe Gadopentetate Dimeglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Gadopentetate Dimeglumine Sales by Country (2021-2026)
- 8.1.3 Europe Gadopentetate Dimeglumine Sales Forecast by Country (2027-2032)
- 8.2 Europe Gadopentetate Dimeglumine Market Size by Country
- 8.2.1 Europe Gadopentetate Dimeglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Gadopentetate Dimeglumine Market Size by Country (2021-2026)
- 8.2.3 Europe Gadopentetate Dimeglumine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Gadopentetate Dimeglumine Sales by Country
- 9.1.1 Asia-Pacific Gadopentetate Dimeglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Gadopentetate Dimeglumine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Gadopentetate Dimeglumine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Gadopentetate Dimeglumine Market Size by Country
- 9.2.1 Asia-Pacific Gadopentetate Dimeglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Gadopentetate Dimeglumine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Gadopentetate Dimeglumine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Gadopentetate Dimeglumine Sales by Country
- 10.1.1 South America Gadopentetate Dimeglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Gadopentetate Dimeglumine Sales by Country (2021-2026)
- 10.1.3 South America Gadopentetate Dimeglumine Sales Forecast by Country (2027-2032)
- 10.2 South America Gadopentetate Dimeglumine Market Size by Country
- 10.2.1 South America Gadopentetate Dimeglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Gadopentetate Dimeglumine Market Size by Country (2021-2026)
- 10.2.3 South America Gadopentetate Dimeglumine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Gadopentetate Dimeglumine Sales by Country
- 11.1.1 Middle East and Africa Gadopentetate Dimeglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Gadopentetate Dimeglumine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Gadopentetate Dimeglumine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Gadopentetate Dimeglumine Market Size by Country
- 11.2.1 Middle East and Africa Gadopentetate Dimeglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Gadopentetate Dimeglumine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Gadopentetate Dimeglumine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Gadopentetate Dimeglumine Value Chain Analysis
- 12.1.1 Gadopentetate Dimeglumine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Gadopentetate Dimeglumine Production Mode & Process
- 12.2 Gadopentetate Dimeglumine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Gadopentetate Dimeglumine Distributors
- 12.2.3 Gadopentetate Dimeglumine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst